Activist 13D/13G Filings - Keros Therapeutics Inc. (KROS)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-13
6:38 pm
Purchase
13GKeros Therapeutics Inc.
KROS
ALKEON CAPITAL MANAGEMENT LLC1,498,907
5%
106,505increase
(+7.65%)
View
2024-02-09
09:16 am
Purchase
13GKeros Therapeutics Inc.
KROS
FMR LLC3,874,204
12.931%
195,115increase
(+5.30%)
View
2024-01-26
5:26 pm
Purchase
13GKeros Therapeutics Inc.
KROS
BlackRock Inc.
BLK
2,036,788
6.8%
398,462increase
(+24.32%)
View
2023-12-13
5:20 pm
Unchanged
13DKeros Therapeutics Inc.
KROS
ORBIMED ADVISORS LLC1,268,734
4.2%
0
(Unchanged)
View
2023-02-14
09:53 am
Sale
13GKeros Therapeutics Inc.
KROS
Deep Track Capital LP0
0%
-1,300,000decrease
(Position Closed)
View
2023-02-13
10:13 am
Purchase
13GKeros Therapeutics Inc.
KROS
ALKEON CAPITAL MANAGEMENT LLC1,392,402
5.1%
1,392,402increase
(New Position)
View
2023-02-09
12:48 pm
Purchase
13GKeros Therapeutics Inc.
KROS
FMR LLC3,679,089
13.357%
174,291increase
(+4.97%)
View
2023-02-07
11:06 am
Purchase
13GKeros Therapeutics Inc.
KROS
BlackRock Inc.
BLK
1,638,326
5.9%
351,800increase
(+27.34%)
View
2023-02-02
2:23 pm
Sale
13GKeros Therapeutics Inc.
KROS
Arkin Moshe1,371,074
4.98%
-441,241decrease
(-24.35%)
View
2022-11-07
4:25 pm
Unchanged
13DKeros Therapeutics Inc.
KROS
ORBIMED ADVISORS LLC1,268,734
4.6%
0
(Unchanged)
View
2022-04-12
06:18 am
Unchanged
13GKeros Therapeutics Inc.
KROS
Arkin Moshe1,812,315
7.55%
0
(Unchanged)
View
2022-04-11
4:57 pm
Sale
13GKeros Therapeutics Inc.
KROS
Arkin Moshe1,812,315
7.55%
-223,825decrease
(-10.99%)
View
2022-02-14
08:58 am
Purchase
13GKeros Therapeutics Inc.
KROS
Deep Track Capital LP1,300,000
5.5%
11,276increase
(+0.87%)
View
2022-02-11
3:13 pm
Sale
13GKeros Therapeutics Inc.
KROS
Foresite Capital Fund IV L.P.0
0%
-1,412,705decrease
(Position Closed)
View
2022-02-09
09:22 am
Purchase
13GKeros Therapeutics Inc.
KROS
FMR LLC3,504,798
14.978%
860,178increase
(+32.53%)
View
2022-02-03
4:29 pm
Purchase
13GKeros Therapeutics Inc.
KROS
BlackRock Inc.
BLK
1,286,526
5.5%
87,325increase
(+7.28%)
View
2021-12-30
4:37 pm
Purchase
13GKeros Therapeutics Inc.
KROS
Deep Track Capital LP1,288,724
5.45%
1,288,724increase
(New Position)
View
2021-02-16
4:00 pm
Purchase
13GKeros Therapeutics Inc.
KROS
Logos Global Master Fund LP450,000
1.9%
450,000increase
(New Position)
View
2021-02-16
10:56 am
Sale
13GKeros Therapeutics Inc.
KROS
Foresite Capital Fund IV L.P.1,412,705
6.1%
-15,366decrease
(-1.08%)
View
2021-02-10
4:48 pm
Sale
13GKeros Therapeutics Inc.
KROS
RA CAPITAL MANAGEMENT L.P.0
0%
-1,875,000decrease
(Position Closed)
View
Goto 0, 1, Next